S

Silo Pharma Inc
NASDAQ:SILO

Watchlist Manager
Silo Pharma Inc
NASDAQ:SILO
Watchlist
Price: 0.4 USD -0.7% Market Closed
Market Cap: 5.3m USD
Section:
 

Relative Value

SILO doesn't have a meaningful market cap.

The Relative Value of one SILO stock under the Base Case scenario is hidden USD. Compared to the current market price of 0.4 USD, Silo Pharma Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SILO Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

73.9
P/S
P/S
Price to Sales
73.9
vs History
90
vs Industry
1
Median 3Y
266
Median 5Y
336.3
Industry
1
Forward
72.5
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-4.9
Median 5Y
-4.4
Industry
17.9
Forward
-0.6
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-6
Median 5Y
-7.7
Industry
10.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-6
Median 5Y
-7.9
Industry
18.1
More Details
1.1
P/B
P/B
Price to Book Value
1.1
vs History
98
vs Industry
54
Median 3Y
3
Median 5Y
3.6
Industry
1.3
More Details
Negative
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
93
vs Industry
Median 3Y
159.7
Median 5Y
216.5
Industry
1.2
Forward
-7.3
More Details
Negative
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
93
vs Industry
Median 3Y
168.4
Median 5Y
224.4
Industry
3.9
More Details
0.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
0.1
vs History
vs Industry
70
Median 3Y
-3
Median 5Y
-4.5
Industry
9.8
More Details
0.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
0.1
vs History
vs Industry
64
Median 3Y
-3
Median 5Y
-4.5
Industry
13.4
Forward
0.1
More Details
0.1
EV/OCF
EV/OCF
Enterprise Value to OCF
0.1
vs History
vs Industry
69
Median 3Y
-3.6
Median 5Y
-5.3
Industry
11.5
More Details
0.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
0.1
vs History
vs Industry
58
Median 3Y
-3.6
Median 5Y
-5.3
Industry
15
More Details
4.6
EV/IC
EV/IC
Enterprise Value to IC
4.6
vs History
vs Industry
8
Median 3Y
-18.5
Median 5Y
-7.4
Industry
1
More Details

Multiples Across Competitors

SILO Competitors Multiples
Silo Pharma Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Silo Pharma Inc
NASDAQ:SILO
5.3m USD 73.9 -1 0.1 0.1
FR
LVMH Moet Hennessy Louis Vuitton SE
PAR:MC
312.8B EUR 3.8 28.5 12.9 18.6
FR
Hermes International SCA
PAR:RMS
223.4B EUR 14.2 49.8 29.1 33.2
KR
SBW
KRX:102280
235.5T KRW 2 563.1 -117 637.1 -79 390.5 -58 109.2
FR
EssilorLuxottica SA
PAR:EL
128.2B EUR 4.7 53.8 20.3 38.5
FR
Christian Dior SE
PAR:CDI
105.7B EUR 1.3 23.2 4.9 7.1
CH
Compagnie Financiere Richemont SA
SIX:CFR
98.9B CHF 4.8 25.8 22 22
FR
Kering SA
PAR:KER
37.9B EUR 2.4 52 12.9 28.8
IN
Titan Company Ltd
NSE:TITAN
3.5T INR 5.1 84 51.4 57.5
DE
Adidas AG
XETRA:ADS
30B EUR 1.2 24.5 10.4 16.7
CN
ANTA Sports Products Ltd
HKEX:2020
232.3B HKD 2.8 14.1 11.4 11.4
P/E Multiple
Earnings Growth PEG
US
S
Silo Pharma Inc
NASDAQ:SILO
Average P/E: 39.5
Negative Multiple: -1 		N/A N/A
FR
LVMH Moet Hennessy Louis Vuitton SE
PAR:MC
28.5
3%
9.5
FR
Hermes International SCA
PAR:RMS
49.8
8%
6.2
KR
SBW
KRX:102280
Negative Multiple: -117 637.1 N/A N/A
FR
EssilorLuxottica SA
PAR:EL
53.8
22%
2.4
FR
Christian Dior SE
PAR:CDI
23.2
N/A N/A
CH
Compagnie Financiere Richemont SA
SIX:CFR
25.8
17%
1.5
FR
Kering SA
PAR:KER
52
8%
6.5
IN
Titan Company Ltd
NSE:TITAN
84
29%
2.9
DE
Adidas AG
XETRA:ADS
24.5
45%
0.5
CN
ANTA Sports Products Ltd
HKEX:2020
14.1
3%
4.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
S
Silo Pharma Inc
NASDAQ:SILO
Average EV/EBITDA: 17.5
0.1
N/A N/A
FR
LVMH Moet Hennessy Louis Vuitton SE
PAR:MC
12.9
0%
N/A
FR
Hermes International SCA
PAR:RMS
29.1
7%
4.2
KR
SBW
KRX:102280
Negative Multiple: -79 390.5 N/A N/A
FR
EssilorLuxottica SA
PAR:EL
20.3
10%
2
FR
Christian Dior SE
PAR:CDI
4.9
N/A N/A
CH
Compagnie Financiere Richemont SA
SIX:CFR
22
8%
2.8
FR
Kering SA
PAR:KER
12.9
-1%
N/A
IN
Titan Company Ltd
NSE:TITAN
51.4
25%
2.1
DE
Adidas AG
XETRA:ADS
10.4
21%
0.5
CN
ANTA Sports Products Ltd
HKEX:2020
11.4
8%
1.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
S
Silo Pharma Inc
NASDAQ:SILO
Average EV/EBIT: 23.4
0.1
N/A N/A
FR
LVMH Moet Hennessy Louis Vuitton SE
PAR:MC
18.6
2%
9.3
FR
Hermes International SCA
PAR:RMS
33.2
7%
4.7
KR
SBW
KRX:102280
Negative Multiple: -58 109.2 N/A N/A
FR
EssilorLuxottica SA
PAR:EL
38.5
18%
2.1
FR
Christian Dior SE
PAR:CDI
7.1
N/A N/A
CH
Compagnie Financiere Richemont SA
SIX:CFR
22
10%
2.2
FR
Kering SA
PAR:KER
28.8
1%
28.8
IN
Titan Company Ltd
NSE:TITAN
57.5
26%
2.2
DE
Adidas AG
XETRA:ADS
16.7
35%
0.5
CN
ANTA Sports Products Ltd
HKEX:2020
11.4
11%
1

See Also

Summary
SILO intrinsic value, competitors valuation, and company profile.
DCF Valuation
SILO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SILO stock valuation using valuation multiples.
Wall Street Estimates
SILO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SILO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 303,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.